Prudential Financial’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-34,567
| Closed | -$325K | – | 2535 |
|
|
2020
Q3 | $325K | Sell |
34,567
-4,810
| -12% | -$45.7K | ﹤0.01% | 2125 |
|
|
2020
Q2 | $301K | Sell |
39,377
-13,180
| -25% | -$101K | ﹤0.01% | 2115 |
|
|
2020
Q1 | $325K | Sell |
52,557
-316,846
| -86% | -$2.79M | ﹤0.01% | 2039 |
|
|
2019
Q4 | $4.5M | Sell |
369,403
-61,099
| -14% | -$668K | 0.01% | 1181 |
|
|
2019
Q3 | $4.97M | Buy |
430,502
+155,648
| +57% | +$1.64M | 0.01% | 1116 |
|
|
2019
Q2 | $2.75M | Buy |
274,854
+23,650
| +9% | +$255K | ﹤0.01% | 1443 |
|
|
2019
Q1 | $3.23M | Sell |
251,204
-58,988
| -19% | -$878K | 0.01% | 1343 |
|
|
2018
Q4 | $4.71M | Buy |
310,192
+119,856
| +63% | +$2.28M | 0.01% | 1124 |
|
|
2018
Q3 | $3.81M | Buy |
190,336
+29,612
| +18% | +$674K | 0.01% | 1307 |
|
|
2018
Q2 | $3.13M | Buy |
160,724
+48,148
| +43% | +$1.07M | ﹤0.01% | 1433 |
|
|
2018
Q1 | $2.27M | Sell |
112,576
-364,606
| -76% | -$6.17M | ﹤0.01% | 1530 |
|
|
2017
Q4 | $6.32M | Sell |
477,182
-248,175
| -34% | -$3.74M | 0.01% | 1054 |
|
|
2017
Q3 | $13.4M | Buy |
725,357
+190,660
| +36% | +$3.55M | 0.02% | 779 |
|
|
2017
Q2 | $9.84M | Buy |
534,697
+198,850
| +59% | +$3.94M | 0.01% | 887 |
|
|
2017
Q1 | $7.57M | Buy |
335,847
+3,700
| +1% | +$88.6K | 0.01% | 962 |
|
|
2016
Q4 | $11.6M | Buy |
332,147
+94,880
| +40% | +$2.83M | 0.02% | 810 |
|
|
2016
Q3 | $5.82M | Sell |
237,267
-205,610
| -46% | -$5.14M | 0.01% | 1002 |
|
|
2016
Q2 | $10.6M | Buy |
442,877
+205,160
| +86% | +$4.7M | 0.02% | 800 |
|
|
2016
Q1 | $5.56M | Buy |
+237,717
| New | +$5.64M | 0.01% | 1041 |
|
|
2015
Q3 | – | Sell |
-2,967
| Closed | -$205K | – | 2275 |
|
|
2015
Q2 | $205K | Sell |
2,967
-7,460
| -72% | -$469K | ﹤0.01% | 2138 |
|
|
2015
Q1 | $570K | Sell |
10,427
-6,600
| -39% | -$315K | ﹤0.01% | 1963 |
|
|
2014
Q4 | $726K | Buy |
+17,027
| New | +$615K | ﹤0.01% | 1843 |
|
|
2014
Q1 | – | Sell |
-12,327
| Closed | -$299K | – | 2299 |
|
|
2013
Q4 | $299K | Sell |
12,327
-100
| -0.8% | -$2.35K | ﹤0.01% | 2088 |
|
|
2013
Q3 | $267K | Buy |
12,427
+300
| +2% | +$7.09K | ﹤0.01% | 2110 |
|
|
2013
Q2 | $270K | Buy |
+12,127
| New | +$267K | ﹤0.01% | 2103 |
|
Prudential Financial's AMAG Position: Q4 2020 in Review
Prudential Financial sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 34,567 shares — an estimated $325K sold.
Prudential Financial first reported a position in AMAG in Q2 2013 and held it in 25 quarters. The position peaked at $13.4M in Q3 2017. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Prudential Financial reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Prudential Financial sold 34,567 AMAG Pharmaceuticals shares in Q4 2020, an estimated $325K.
- Prudential Financial first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 25 quarters.
- Prudential Financial's AMAG Pharmaceuticals position peaked at $13.4M in Q3 2017.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Prudential Financial's 13F filing for Q4 2020, filed 16 Feb 2021.